“There is no greater risk. Of 17 million vaccinated, 37 embolism and thrombosis events “

Here comes the voice of AstraZeneca. “A careful review of all available safety data from more than 17 million people vaccinated in the EU and UK with the AstraZeneca Covid-19 vaccine showed no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any age, group, sex, lot or in a particular country. ” AstraZeneca states this. Following the “recent concern raised by thrombotic events – notes the company – AstraZeneca wishes to provide assurance on the safety of its vaccine based on clear scientific evidence.” The company “continually monitors security.”

So far, in Europe and the UK, out of a total of 17 million subjects vaccinated with AstraZeneca’s Covid vaccine, “ 15 episodes of DVT and 22 episodes of pulmonary embolism have been reported among those given the vaccine, depending on the number of cases. the Company received as of March 8 ”. This was stated by AstraZeneca, underlining that this number of events “is much lower than what one would expect to occur naturally in a general population of this size and is similar for other licensed Covid-19 vaccines.”

“There is no problem in any batch”

In terms of quality, “there are no confirmed problems with any batch of our vaccine used in Europe or the rest of the world.” AstraZeneca states this. “Other tests – specifies the company – have been and are being carried out by us and independently by the European health authorities and none of these new tests has proven to be a cause for concern.” During vaccine production, “AstraZeneca, its partners and more than 20 independent testing laboratories perform more than 60 quality tests.”

Coronavirus bulletin today: 21,315 cases and 264 deaths

AstraZeneca, the intervention of Aifa

«The alarm about the safety of the vaccine is unjustified AstraZeneca“The Italian Medicines Agency (Aifa) writes it in a note, underlining that the cases of death that occurred after the administration of the vaccine” have only a temporary link. Causality between the two events has not been proven. ” “that pharmacovigilance activities continue both at national and European level in collaboration with Ema, carefully monitoring possible adverse effects related to vaccination” and “strongly reassures citizens about the safety of the AstraZeneca vaccine for optimal adherence to the campaign vaccination “.

Last updated: 20:51


© REPRODUCTION RESERVED